| 9.16 0.12 (1.33%) | 10-15 12:16 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 11.27 |
1-year : | 13.16 |
| Resists | First : | 9.64 |
Second : | 11.27 |
| Pivot price | 8.95 |
|||
| Supports | First : | 9.01 |
Second : | 8.61 |
| MAs | MA(5) : | 8.9 |
MA(20) : | 8.96 |
| MA(100) : | 9.13 |
MA(250) : | 9.49  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 33 |
D(3) : | 22.6 |
| RSI | RSI(14): 52.3 |
|||
| 52-week | High : | 11.63 | Low : | 7.1 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AHCO ] has closed below upper band by 26.9%. Bollinger Bands are 13.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.06 - 9.1 | 9.1 - 9.13 |
| Low: | 8.53 - 8.57 | 8.57 - 8.61 |
| Close: | 8.97 - 9.04 | 9.04 - 9.1 |
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Tue, 07 Oct 2025
AdaptHealth Corp. (AHCO) Stock Analysis: A 46% Potential Upside Ignites Investor Interest - DirectorsTalk Interviews
Thu, 02 Oct 2025
3 Reasons to Sell AHCO and 1 Stock to Buy Instead - The Globe and Mail
Sun, 28 Sep 2025
AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Wed, 24 Sep 2025
Truist Financial Remains Bullish on AdaptHealth (AHCO) - MSN
Sat, 23 Aug 2025
AdaptHealth Corp. Stock (AHCO) Opinions on Q2 Earnings and New Partnership - Quiver Quantitative
Tue, 05 Aug 2025
AdaptHealth Secures Massive 5-Year Deal as Exclusive Home Medical Provider for 10M+ Patients - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 135 (M) |
| Shares Float | 89 (M) |
| Held by Insiders | 8.1 (%) |
| Held by Institutions | 103.9 (%) |
| Shares Short | 10,350 (K) |
| Shares Short P.Month | 10,440 (K) |
| EPS | 0.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12 |
| Profit Margin | 2.4 % |
| Operating Margin | 7 % |
| Return on Assets (ttm) | 3.7 % |
| Return on Equity (ttm) | 5.5 % |
| Qtrly Rev. Growth | -0.7 % |
| Gross Profit (p.s.) | 5.16 |
| Sales Per Share | 23.94 |
| EBITDA (p.s.) | 4.67 |
| Qtrly Earnings Growth | -23.4 % |
| Operating Cash Flow | 552 (M) |
| Levered Free Cash Flow | 235 (M) |
| PE Ratio | 16.92 |
| PEG Ratio | 0 |
| Price to Book value | 0.76 |
| Price to Sales | 0.38 |
| Price to Cash Flow | 2.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|